Cargando…

ERp29 inhibits tumorigenicity by suppressing epithelial mesenchymal transition in gastric cancer

ERp29 is a novel endoplasmic reticulum (ER) protein that plays an important role in protein unfolding and secretion. Recently, it has been reported to be widely implicated in control of tumorigenesis in some tumors. However, the potential function of ERp29 in gastric cancer remains poorly understood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jing, Yang, Yuanyan, Gao, Shenshen, Jiang, Hong, Wang, Xin-Qiong, Xiao, Yuan, Chen, Xue-Hua, Li, Pu, Xu, Chun-Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667996/ https://www.ncbi.nlm.nih.gov/pubmed/29108263 http://dx.doi.org/10.18632/oncotarget.20225

Ejemplares similares

ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion
por: Wu, Jing, et al.
Publicado: (2015)

ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway
por: Ye, Jianxin, et al.
Publicado: (2017)

The Role of Cancer-Derived Exosomes in Tumorigenicity & Epithelial-to-Mesenchymal Transition
por: Blackwell, Robert H., et al.
Publicado: (2017)

Friend or foe: Endoplasmic reticulum protein 29 (ERp29) in epithelial cancer
por: Chen, Shaohua, et al.
Publicado: (2015)

Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Rotavirus Induces Epithelial–Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b
por: Mukhopadhyay, Urbi, et al.
Publicado: (2021)

Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells
por: He, Xiaoqing, et al.
Publicado: (2017)

SCARA5 inhibits gastric cancer progression via epithelial-mesenchymal transition suppression
por: Zhang, Hangyu, et al.
Publicado: (2021)

DAXX inhibits cancer stemness and epithelial–mesenchymal transition in gastric cancer
por: Wu, Chaofan, et al.
Publicado: (2020)

Marine Depsipeptide Nobilamide I Inhibits Cancer Cell Motility and Tumorigenicity via Suppressing Epithelial–Mesenchymal Transition and MMP2/9 Expression
por: Le, Tu Cam, et al.
Publicado: (2022)

miR-665 Suppresses the Epithelial–Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer
por: Jia, Litao, et al.
Publicado: (2013)

Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer
por: Su, Bo, et al.
Publicado: (2016)

The Probable, Possible, and Novel Functions of ERp29
por: Brecker, Margaret, et al.
Publicado: (2020)

ERp29 as a regulator of Insulin biosynthesis
por: Viviano, Jeffrey, et al.
Publicado: (2020)

Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer
por: Chen, Jia, et al.
Publicado: (2014)

WTX inhibits gastric cancer migration through the reversal of epithelial-mesenchymal transition
por: Ye, Danli, et al.
Publicado: (2018)

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
por: Zang, Ming-de, et al.
Publicado: (2017)

MicroRNA-29b suppresses TGF-β-induced epithelial-mesenchymal transition in renal interstitium of spontaneously hypertensive rats
por: Wu, Yihao, et al.
Publicado: (2022)

Aqueous Huaier Extract Suppresses Gastric Cancer Metastasis and Epithelial to Mesenchymal Transition by Targeting Twist
por: Xu, Zhiyuan, et al.
Publicado: (2017)

“Pulsed Hypoxia” Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal–Epithelial Transition
por: Nushtaeva, Anna, et al.
Publicado: (2023)

EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice
por: Lu, Ling, et al.
Publicado: (2016)

Correction: ERp29 as a regulator of Insulin biosynthesis
por: Viviano, Jeffrey, et al.
Publicado: (2020)

microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition
por: PENG, YANG, et al.
Publicado: (2014)

Lobetyolin suppressed lung cancer in a mouse model by inhibiting epithelial-mesenchymal transition
por: Liu, Lu, et al.
Publicado: (2022)

Alteration of N-glycans and Expression of Their Related Glycogenes in the Epithelial-Mesenchymal Transition of HCV29 Bladder Epithelial Cells
por: Guo, Jia, et al.
Publicado: (2014)

Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches
por: Kozak, Joanna, et al.
Publicado: (2020)

ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer
por: Wei, Xiao-Long, et al.
Publicado: (2015)

NLRP6, decreased in gastric cancer, suppresses tumorigenicity of gastric cancer cells
por: Wang, Qingqing, et al.
Publicado: (2018)

miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial–mesenchymal transition
por: Wang, B, et al.
Publicado: (2014)

microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer
por: Chen, Gen, et al.
Publicado: (2020)

Epicardial epithelial-to-mesenchymal transition in injured heart
por: Zhou, Bin, et al.
Publicado: (2011)

ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer
por: Guo, Lili, et al.
Publicado: (2019)

Generation of Stable Epithelial–Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential
por: Tedja, Roslyn, et al.
Publicado: (2023)

TAZ Controls Helicobacter pylori-Induced Epithelial–Mesenchymal Transition and Cancer Stem Cell-Like Invasive and Tumorigenic Properties
por: Tiffon, Camille, et al.
Publicado: (2020)

Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells
por: Lee, Da-Young, et al.
Publicado: (2021)

Zyxin inhibits the epithelial–mesenchymal transition process in gastric cancer by upregulating SIRT1
por: Lou, Jing, et al.
Publicado: (2023)

AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells
por: Yoshinaga, Tomoyo, et al.
Publicado: (2016)

Gastric cancer cell growth and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT
por: LI, LU-CHUN, et al.
Publicado: (2014)

FZD5 prevents epithelial-mesenchymal transition in gastric cancer
por: Dong, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_em6b51dk5r7noh6102bjevdepp